Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 74 Breast Neoplasms 70 Rectal Neoplasms 51 Stomach Neoplasms 45 Glioblastoma 45 Esophageal Neoplasms 41 Colorectal Neoplasms 37 Lung Neoplasms 35 Brain Neoplasms 35 Squamous Cell Carcinoma of Head and Neck 32 Pancreatic Neoplasms 31 Glioma 27 Neoplasms 26 Sarcoma 23 Neoplasm Metastasis 23 Astrocytoma 22 Head and Neck Neoplasms 21 Carcinoma, Hepatocellular 18 Esophageal Squamous Cell Carcinoma 16 Colonic Neoplasms 16 Recurrence 15 Ovarian Neoplasms 15 Melanoma 15 Gliosarcoma 15 Central Nervous System Neoplasms 15 Urinary Bladder Neoplasms 13 Oligodendroglioma 13 Uterine Cervical Neoplasms 12 Adenocarcinoma Of Esophagus 12 Prostatic Neoplasms 11

Interventions

Cabergoline 6 Dopamine Agonists 2 ropinirole 1 pasireotide 1 Tissue Banks 1 Temozolomide 1 Surgical Procedures, Operative 1 Standard of Care 1 Microarray Analysis 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Early Intervention, Educational 1 Dexamethasone 1 DNA Methylation 1 Clomiphene 1 Calcium Dobesilate 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prolactinoma × Surgical Procedures, Operative × Clear all

NCT03717454 2018-11-20

Dopamine D2 Receptors(D2R) Imaging in Prolactinomas

Ruijin Hospital

Phase NA Unknown

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡